All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

It is well known that among elderly people with dementia there is a high prevalence of psychotic symptoms. However, studies of psychotic symptoms in the elderly without dementia are scarce. This gap in our understanding may negatively influence the diagnosis and clinical management of this population \[[@pone.0178471.ref001]\] \[[@pone.0178471.ref002]\].

Henderson et al. (1998) are among the few investigators that have addressed this question. They found a cumulative incidence of psychotic symptoms of 4.8% in a 3-year follow-up period of a sample of cognitively intact people aged 70 and over \[[@pone.0178471.ref002]\]. Other authors have estimated the cumulative incidence to be 4.8% in people aged 70--90 based on psychiatric examinations and medical records, 8.0% when key-informant reports were included, and 19.8% among those re-evaluated at 85 years of age \[[@pone.0178471.ref003]\].

The presence of psychotic symptoms in this population may be of important prognostic value, since it has been shown that cognitively intact individuals with psychotic symptoms have an increased risk of developing dementia (OR: 2,5--3,5) \[[@pone.0178471.ref003],[@pone.0178471.ref004],[@pone.0178471.ref005]\]. Amongst individuals without dementia who exhibited psychotic symptoms, 44% developed dementia during a 20 year follow-up period, with hallucinations (particularly visual hallucinations) being the main symptom associated with more rapid cognitive decline \[[@pone.0178471.ref003]\] \[[@pone.0178471.ref005]\].

Our data form part of a large epidemiological study of a cohort of individuals over the age of 60 and living in the city of São Paulo, Brazil. Data from this study (phase I of the present study) have already been published estimating the prevalence of dementia \[[@pone.0178471.ref006]\] and psychotic symptoms in those without dementia \[[@pone.0178471.ref007]\] in this Brazilian population.

We previously showed that the prevalence of general psychotic symptoms in this community sample was 9.1%; the breakdown of which was 7.5% auditory hallucinations, 7.8% other types of hallucinations and 2.9% persecutory delusions. A significant relationship was found between the presence of psychotic symptoms and a lower Mini Mental State Examination score, fewer years of schooling as well as a lower socioeconomic status. Comorbidities were also very frequent such as head trauma, depression, diabetes, Chagas Disease, arthritis and alcohol abuse \[[@pone.0178471.ref007]\].

This same cohort was followed up over seven years and the results of this period of observation are the focus of the present paper. Here we examine the incidence of psychotic symptoms in subjects over 60 years of age without dementia, the rate of development of cognitive impairment and the correlation of these symptoms with socioeconomic and clinical characteristics.

Methods {#sec006}
=======

Sample selection {#sec007}
----------------

This study examines a sub-population of a larger clinical-epidemiological study that investigated the prevalence and etiology of dementia in a community-based sample of individuals aged over 60 and living in São Paulo, Brazil \[[@pone.0178471.ref006]\]. We selected those subjects that, at enrolment, did not have cognitive impairment or clinically significant Depressive Symptoms (CSDS).

The study protocol was approved by the University of São Paulo General Hospital (CAPPesq---Protocol number: 1113/07), and all the subjects gave their informed written consent.

According to census data from 2000, the city of São Paulo had approximately 970,000 people who were over 60 years of age \[[@pone.0178471.ref008]\]. This census ranked 96 city districts from the wealthiest to the poorest, which were divided into 3 groups; one district of each socioeconomic stratum was chosen to represent the upper, middle and lower groups \[[@pone.0178471.ref006]\].

As previously described, the dementia prevalence of 7% was based on a published study of a Brazilian elderly population \[[@pone.0178471.ref009]\]. Using the same parameters, we calculated the required sample size to be 1,100 (using the Epi Info 6 software---<https://www.cdc.gov/epiinfo/pc.html>). This number was then multiplied by 1.5 as a correction factor and, adding 20% for the possible losses, we obtained a final sample size of 2,062 individuals \[[@pone.0178471.ref006]\].

Together, the three chosen districts had an elderly population of 64,760. Thirty areas from each district were selected, and 10 houses were randomly chosen from each area. After local media advertisement, the researchers visited 8,042 houses. 2,233 individuals older than 60 years were selected and from these 1,563 agreed to participate. They were asked to respond to a questionnaire about their socioeconomic and clinical status. They were also evaluated using a number of instruments: the Mini Mental State Examination (MMSE) \[[@pone.0178471.ref010]\], the Fuld Object Memory Evaluation (FOME) \[[@pone.0178471.ref011]\], the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) \[[@pone.0178471.ref012]\], the Bayer Activities of Daily Living scale (B-ADL) \[[@pone.0178471.ref013]\] and the Scale to Screen Depressive Symptoms in Older People (D-10) \[[@pone.0178471.ref014]\]). These 1,563 individuals constituted the sample of the large clinical-epidemiological study about dementia and cognitive impairment \[[@pone.0178471.ref007]\] of which our study is part.

Individuals were considered positive in the screen for dementia or cognitive and functional impairment if they scored below the cutoff point on one of the cognitive tests (MMSE \< 20---illiterate subjects; MMSE \< 25--1--4 years of schooling; MMSE \< 27--5--8 years of schooling; MMSE \< 28 --more than 9 years of schooling; FOME \< 35) and above the cutoff point on one functional scale (IQCODE \> 3.4 and B-ADL \> 3.19) \[[@pone.0178471.ref007]\]. The cutoff point for clinically significant Depressive Symptoms (CSDS) on the D-10 scale was ≥ 7 \[[@pone.0178471.ref015]\].

From the initial sample of 1,563 subjects, we excluded individuals who screened positive for dementia, cognitive and functional impairment, or CSDS, resulting in 1,125 individuals, which was the sample of the first phase of our study (2004), which has been reported elsewhere \[[@pone.0178471.ref007]\].

In December 2010, we contacted the subjects from the first phase sample using letters, e-mails and phone calls to explain and invite them to the second phase. After one month (January 2011), 690 new interviews were conducted, which included the reapplication of the questionnaire from the first phase.

From this sample of 690 individuals, 547 with no initial cognitive decline (2004) were re-evaluated using the same protocol as the original study 7 years earlier. From this sample, 284 had a positive screening for dementia or CSDS in 2011. Of the remaining 263 subjects, 199 did not have psychotic symptoms at phase I and thus constituted the sample used to evaluate the incidence of psychotic symptoms, while the 64 individuals who already had psychotic symptoms in 2004 constituted the sample used to evaluate rate of conversion to cognitive decline. ([Fig 1](#pone.0178471.g001){ref-type="fig"}). (see [Fig 1](#pone.0178471.g001){ref-type="fig"})

![Study sample flowchart.](pone.0178471.g001){#pone.0178471.g001}

Instruments {#sec008}
-----------

A questionnaire was used to screen for dementia, cognitive and functional impairment and CSDS. It contained questions regarding clinical and socioeconomic status. It was divided into the following sections: subject personal information, caregiver personal information (the caregiver being required to be a family member or a close friend) and personal history and habits. Trained interviewers investigated the presence of previous medical diagnoses. Common medical comorbidities such as hypertension, diabetes and cerebral vascular accident were evaluated through objective and direct questions. Family history was also explored. Subjects were questioned directly when cognitively intact and a collateral history was obtained when they were cognitively impaired. Issues around the use of health services were explored, including the use of public services via the universal public health system available by right to all Brazilians, or private healthcare such as health insurance or private consultations, or no use of health services, either in terms of primary care, secondary care (inpatient or outpatient) or tertiary centres.

Other aspects were also evaluated such as instrumental and physical activities, depressive symptoms (D-10 \[[@pone.0178471.ref014]\]), socioeconomic status based on the ABIPEME (Brazilian Association of Market Research) questionnaire, as well as cognitive/functional evaluation using the MMSE \[[@pone.0178471.ref010]\], FOME \[[@pone.0178471.ref011]\], IQCODE \[[@pone.0178471.ref012]\] and B-ADL \[[@pone.0178471.ref013]\]--last both completed by the caregiver.

We used the following three questions for the screening of psychotic symptoms, which were extracted from the Cambridge Mental Disorders of the Elderly Examination (CAMDEX), adapted for and translated to Brazilian Portuguese \[[@pone.0178471.ref016],[@pone.0178471.ref017]\]: Do you have, or have you ever had, the experience of hearing things that other people do not? Do you ever have the experience of seeing things that other people do not? Do you ever believe that people are watching you, spying on you, or plotting against you?

Statistical analysis {#sec009}
--------------------

The data were stored and analyzed using the Statistical Package for the Social Sciences version 16.0 for Windows (SPSS, developed by SPSS Inc. in Chicago, USA). Initially, we calculated the incidence of all psychotic symptoms in 7 years, then the incidence for each category.

The Mann--Whitney test was used to compare continuous variables between groups of individuals with and without psychotic symptoms. The same test was used to compare groups of cognitively impaired and cognitively intact individuals with psychotic symptoms. The Kruskall- Wallis test was used to compare samples of individuals with no psychotic symptoms against those with at least one, two or three psychotic symptoms, respectively. The chi-squared test was used to compare categorical variables within the same groups.

To evaluate the association between important variables and possible risk factors for psychotic symptom development, a stepwise backward multiple logistic regression was calculated for each of the psychotic symptoms (dependent variables) as well as the following variables that reached statistical significance at the bivariate analysis: MMSE, diabetes, epilepsy, reported depression and syphilis. Variables that had significance in the first phase of the study such as gender, years of schooling, B-ADL socioeconomic classification and Chagas Disease were entered as predictors or independents variables in the second phase.

Another stepwise backward multiple logistic regression was calculated to verify an association between each psychotic symptom (independent variables) with the development cognitive impairment (dependent variable) in the sample of 64 individuals who already had psychotic symptoms at 2004. The level of significance adopted was 5%.

Results {#sec010}
=======

Sample description {#sec011}
------------------

We studied two sub-samples, one without and the other with psychotic symptoms in Phase I. In both sub-samples, more than 90% of the participants were between 80 and 90 years of age, and were predominantly women (almost 70%). More than 80% of the participants were married or widowed. Both sub-samples had 4 important characteristics: participants were retired or had no labor activity (80.9 and 82.8%), had some type of clinical comorbidity (83.4 and 87.5%), belonged to the B or C socioeconomic classes (75.3 and 76.6%) and were not using psychotropic medication (82.9 and 71.9%) ([Table 1](#pone.0178471.t001){ref-type="table"}).

10.1371/journal.pone.0178471.t001

###### Demographic characteristics of the sample.

![](pone.0178471.t001){#pone.0178471.t001g}

  Variables                      Individuals *N* (%)                
  ------------------------------ --------------------- ------------ -----------
  Age group                      80--90 years          198 (99.5)   60 (93.8)
  More than 90 years             1 (0.5)               4 (6.3)      
  Gender                         Male                  72 (36.2)    17 (26.6)
  Female                         127 (63.8)            47 (73.4)    
  Civil Status                   Single                17 (8.5)     2 (3.1)
  Married                        99 (49.7)             25 (39.1)    
  Divorced                       6 (3.0)               6 (9.4)      
  Widowed                        73 (36.7)             31 (48.4)    
  Other                          2 (1.0)               0 (0.0)      
  Years of Schooling             0                     0 (0.0)      1 (2.1)
  1 a 4                          71 (38.0)             27 (56.3)    
  5 a 8                          27 (14.4)             5 (10.4)     
  9 a 12                         27 (14.4)             6 (12.5)     
  13 or more                     62 (33.2)             9 (18.8)     
  Socioeconomic Classification   A                     41 (20.6)    6 (9.4)
  B                              93 (46.7)             25 (39.1)    
  C                              57 (28.6)             24 (37.5)    
  D                              8 (4.0)               9 (14.1)     
  E                              0 (0.0)               0 (0.0)      
  Labour Activity                Yes                   16 (8.0)     3 (4.7)
  No                             161 (80.9)            53 (82.8)    
  Comorbidity                    Yes                   166 (83.4)   56 (87.5)
  No                             33 (16.6)             8 (12.5)     
  Psychotropic Medication Use    Yes                   34 (17.1)    17 (26.6)
  No                             165 (82.9)            46 (71.9)    

Psychotic symptoms incidence {#sec012}
----------------------------

The incidence of at least one psychotic symptom over the 7 year follow up was 8.0%, and the incidence of at least two psychotic symptoms was 1.0%. Visual and tactile hallucinations were the most frequent (4.5%), followed by persecutory delusions (3.0%) then auditory hallucinations (2.5%).

Cognitive aspects {#sec013}
-----------------

The individuals who developed psychotic symptoms had a lower mean MMSE score at Phase II than subjects without psychotic symptoms (22.8 vs. 25.9, p ≤ 0.01). Individuals who reported to have persecutory delusions had a particularly low MMSE mean score (19.0). Between groups there was no statistical difference in terms of activities of daily living (B-ADL) or years of schooling (Tables [2](#pone.0178471.t002){ref-type="table"} and [3](#pone.0178471.t003){ref-type="table"}).

10.1371/journal.pone.0178471.t002

###### Relationship between type of psychotic symptom, cognitive impairment (MMSE), functional status (B-ADL) and use of health services.

![](pone.0178471.t002){#pone.0178471.t002g}

                                          MMSE                                          B-ADL                                        Health Service Used                                                                                                                   
  --------------------------------------- --------------------------------------------- -------------------------------------------- ------------------------------------------- -------------------------------------------- -------------------------------------------- ---------------------------------------------
  With auditory hallucinations            24.00[^b^](#t002fn002){ref-type="table-fn"}   2.25[^b^](#t002fn002){ref-type="table-fn"}   0.0[^b^](#t002fn002){ref-type="table-fn"}   0.0[^b^](#t002fn002){ref-type="table-fn"}    0.0[^b^](#t002fn002){ref-type="table-fn"}    100,0[^b^](#t002fn002){ref-type="table-fn"}
  Without auditory hallucinations         25.69[^b^](#t002fn002){ref-type="table-fn"}   1.81[^b^](#t002fn002){ref-type="table-fn"}   0.5[^b^](#t002fn002){ref-type="table-fn"}   22.0[^b^](#t002fn002){ref-type="table-fn"}   44.0[^b^](#t002fn002){ref-type="table-fn"}   33.0[^b^](#t002fn002){ref-type="table-fn"}
  With visual/tactile hallucinations      24.11[^b^](#t002fn002){ref-type="table-fn"}   2.28[^b^](#t002fn002){ref-type="table-fn"}   0.0[^b^](#t002fn002){ref-type="table-fn"}   11.1[^b^](#t002fn002){ref-type="table-fn"}   44.4[^b^](#t002fn002){ref-type="table-fn"}   44.4[^b^](#t002fn002){ref-type="table-fn"}
  Without visual/tactile hallucinations   25.72[^b^](#t002fn002){ref-type="table-fn"}   1.80[^b^](#t002fn002){ref-type="table-fn"}   0.5[^b^](#t002fn002){ref-type="table-fn"}   21.9[^b^](#t002fn002){ref-type="table-fn"}   42.8[^b^](#t002fn002){ref-type="table-fn"}   34.2[^b^](#t002fn002){ref-type="table-fn"}
  With persecutory delusions              19.00[^a^](#t002fn001){ref-type="table-fn"}   2.30[^b^](#t002fn002){ref-type="table-fn"}   0.0[^b^](#t002fn002){ref-type="table-fn"}   0.0[^b^](#t002fn002){ref-type="table-fn"}    50.0[^b^](#t002fn002){ref-type="table-fn"}   50.0[^b^](#t002fn002){ref-type="table-fn"}
  Without persecutory delusions           25.84[^a^](#t002fn001){ref-type="table-fn"}   1.80[^b^](#t002fn002){ref-type="table-fn"}   0.5[^b^](#t002fn002){ref-type="table-fn"}   22.2[^b^](#t002fn002){ref-type="table-fn"}   42.3[^b^](#t002fn002){ref-type="table-fn"}   34.4[^b^](#t002fn002){ref-type="table-fn"}
  No psychotic symptoms                   25.94[^a^](#t002fn001){ref-type="table-fn"}   1.77[^b^](#t002fn002){ref-type="table-fn"}   0.6[^b^](#t002fn002){ref-type="table-fn"}   23.0[^b^](#t002fn002){ref-type="table-fn"}   43.8[^b^](#t002fn002){ref-type="table-fn"}   32.0[^b^](#t002fn002){ref-type="table-fn"}
  1 psychotic symptom                     22.81[^a^](#t002fn001){ref-type="table-fn"}   2.26[^b^](#t002fn002){ref-type="table-fn"}   0.0[^b^](#t002fn002){ref-type="table-fn"}   6.2[^b^](#t002fn002){ref-type="table-fn"}    31.2[^b^](#t002fn002){ref-type="table-fn"}   62.5[^b^](#t002fn002){ref-type="table-fn"}
  2 psychotic symptoms                    21.50[^a^](#t002fn001){ref-type="table-fn"}   2.38[^b^](#t002fn002){ref-type="table-fn"}   0.0[^b^](#t002fn002){ref-type="table-fn"}   0.0[^b^](#t002fn002){ref-type="table-fn"}    50.0[^b^](#t002fn002){ref-type="table-fn"}   50.0[^b^](#t002fn002){ref-type="table-fn"}

^a^ p ≤ 0.01

^b^ p \> 0.05

10.1371/journal.pone.0178471.t003

###### Relation between psychotic symptoms, years of schooling and socioeconomic status.

![](pone.0178471.t003){#pone.0178471.t003g}

                                          Years of schooling (%)                        Socioeconomic classes (%)                                                                                                                                                                                                                                                       
  --------------------------------------- --------------------------------------------- --------------------------------------------- --------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------
  With auditory hallucinations            50.0 [^b^](#t003fn002){ref-type="table-fn"}   25.0 [^b^](#t003fn002){ref-type="table-fn"}   25.0 [^b^](#t003fn002){ref-type="table-fn"}   0.0[^b^](#t003fn002){ref-type="table-fn"}    40.0[^b^](#t003fn002){ref-type="table-fn"}   40.0[^b^](#t003fn002){ref-type="table-fn"}   20.0[^b^](#t003fn002){ref-type="table-fn"}   0.0[^b^](#t003fn002){ref-type="table-fn"}
  Without auditory hallucinations         37.7 [^b^](#t003fn002){ref-type="table-fn"}   14.2 [^b^](#t003fn002){ref-type="table-fn"}   48.1 [^b^](#t003fn002){ref-type="table-fn"}   21.1[^b^](#t003fn002){ref-type="table-fn"}   46.9[^b^](#t003fn002){ref-type="table-fn"}   28.4[^b^](#t003fn002){ref-type="table-fn"}   3.6[^b^](#t003fn002){ref-type="table-fn"}    0.0[^b^](#t003fn002){ref-type="table-fn"}
  With visual/tactile hallucinations      55.6 [^b^](#t003fn002){ref-type="table-fn"}   11.1 [^b^](#t003fn002){ref-type="table-fn"}   33.3 [^b^](#t003fn002){ref-type="table-fn"}   11.1[^b^](#t003fn002){ref-type="table-fn"}   33.3[^b^](#t003fn002){ref-type="table-fn"}   55.6[^b^](#t003fn002){ref-type="table-fn"}   0.0[^b^](#t003fn002){ref-type="table-fn"}    0.0[^b^](#t003fn002){ref-type="table-fn"}
  Without visual/tactile hallucinations   37.1 [^b^](#t003fn002){ref-type="table-fn"}   14.6 [^b^](#t003fn002){ref-type="table-fn"}   48.3 [^b^](#t003fn002){ref-type="table-fn"}   21.1[^b^](#t003fn002){ref-type="table-fn"}   47.4[^b^](#t003fn002){ref-type="table-fn"}   27.4[^b^](#t003fn002){ref-type="table-fn"}   4.2[^b^](#t003fn002){ref-type="table-fn"}    0.0[^b^](#t003fn002){ref-type="table-fn"}
  With persecutory delusions              75.0 [^b^](#t003fn002){ref-type="table-fn"}   0.0 [^b^](#t003fn002){ref-type="table-fn"}    25.0 [^b^](#t003fn002){ref-type="table-fn"}   0.0[^b^](#t003fn002){ref-type="table-fn"}    33.3[^b^](#t003fn002){ref-type="table-fn"}   50.0[^b^](#t003fn002){ref-type="table-fn"}   16.7[^b^](#t003fn002){ref-type="table-fn"}   0.0[^b^](#t003fn002){ref-type="table-fn"}
  Without persecutory delusions           36.8 [^b^](#t003fn002){ref-type="table-fn"}   14.8 [^b^](#t003fn002){ref-type="table-fn"}   48.4 [^b^](#t003fn002){ref-type="table-fn"}   21.4[^b^](#t003fn002){ref-type="table-fn"}   47.4[^b^](#t003fn002){ref-type="table-fn"}   27.6[^b^](#t003fn002){ref-type="table-fn"}   3.6[^b^](#t003fn002){ref-type="table-fn"}    0.0[^b^](#t003fn002){ref-type="table-fn"}
  No psychotic symptoms                   36.0 [^b^](#t003fn002){ref-type="table-fn"}   14.5 [^b^](#t003fn002){ref-type="table-fn"}   49.4 [^b^](#t003fn002){ref-type="table-fn"}   22.1[^b^](#t003fn002){ref-type="table-fn"}   48.1[^b^](#t003fn002){ref-type="table-fn"}   26.5[^b^](#t003fn002){ref-type="table-fn"}   3.3[^b^](#t003fn002){ref-type="table-fn"}    0.0[^b^](#t003fn002){ref-type="table-fn"}
  1 psychotic symptom                     11.3 [^b^](#t003fn002){ref-type="table-fn"}   15.4 [^b^](#t003fn002){ref-type="table-fn"}   23.1 [^b^](#t003fn002){ref-type="table-fn"}   6.2[^b^](#t003fn002){ref-type="table-fn"}    31.2[^b^](#t003fn002){ref-type="table-fn"}   50.0[^b^](#t003fn002){ref-type="table-fn"}   12.5[^b^](#t003fn002){ref-type="table-fn"}   0.0[^b^](#t003fn002){ref-type="table-fn"}
  2 psychotic symptoms                    50.0 [^b^](#t003fn002){ref-type="table-fn"}   0.0 [^b^](#t003fn002){ref-type="table-fn"}    50.0 [^b^](#t003fn002){ref-type="table-fn"}   0.0[^b^](#t003fn002){ref-type="table-fn"}    50.0[^b^](#t003fn002){ref-type="table-fn"}   50.0[^b^](#t003fn002){ref-type="table-fn"}   0.0[^b^](#t003fn002){ref-type="table-fn"}    0.0[^b^](#t003fn002){ref-type="table-fn"}

^a^: p ≤ 0.01;

^b^ \> 0.05.

Socioeconomic aspects {#sec014}
---------------------

Differences in socioeconomic class and use of health services did not reach statistical significance between groups. However, there is a clear trend with the majority of patients with psychotic symptoms belonging to classes C and D and those without belonging to classes A and B. The use of the public health system and health insurance was more frequent among elderly people with psychotic symptoms (Tables [2](#pone.0178471.t002){ref-type="table"} and [3](#pone.0178471.t003){ref-type="table"}).

Comorbidities {#sec015}
-------------

Almost 84% of the sample had at least one comorbidity. A large proportion of individuals with auditory hallucinations (when compared to those without) were shown to have syphilis (20.0% vs. 0.5%, p ≤ 0.01). Diabetes was more frequent in individuals with visual/tactile hallucinations (33.3% vs. 20.5%, p ≤ 0.05). Depression was reported more frequently by those with persecutory delusions compared to those without delusions (50.0% vs. 12.6%, p ≤ 0.05) ([Table 4](#pone.0178471.t004){ref-type="table"}).

10.1371/journal.pone.0178471.t004

###### Frequency of comorbidities by psychotic symptom type (%).

![](pone.0178471.t004){#pone.0178471.t004g}

                                          CVA                                         CET                                         DEP                                          DM                                           EPI                                          AMI                                          SYP                                          CD                                          ART
  --------------------------------------- ------------------------------------------- ------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- ------------------------------------------- --------------------------------------------
  With auditory hallucinations            0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}   20.0[^c^](#t004fn003){ref-type="table-fn"}   40.0[^c^](#t004fn003){ref-type="table-fn"}   20.0[^c^](#t004fn003){ref-type="table-fn"}   20.0[^c^](#t004fn003){ref-type="table-fn"}   20.0[^a^](#t004fn001){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}   60.0[^c^](#t004fn003){ref-type="table-fn"}
  Without auditory hallucinations         3.1[^c^](#t004fn003){ref-type="table-fn"}   2.6[^c^](#t004fn003){ref-type="table-fn"}   13.5[^c^](#t004fn003){ref-type="table-fn"}   20.6[^c^](#t004fn003){ref-type="table-fn"}   1.6[^c^](#t004fn003){ref-type="table-fn"}    8.8[^c^](#t004fn003){ref-type="table-fn"}    0.5[^a^](#t004fn001){ref-type="table-fn"}    0.5[^c^](#t004fn003){ref-type="table-fn"}   21.1[^c^](#t004fn003){ref-type="table-fn"}
  With visual/tactile hallucinations      0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}    33.3[^b^](#t004fn002){ref-type="table-fn"}   11.1[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}    0.0[^b^](#t004fn002){ref-type="table-fn"}    0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}
  Without visual/tactile hallucinations   0.0[^c^](#t004fn003){ref-type="table-fn"}   2.6[^c^](#t004fn003){ref-type="table-fn"}   14.3[^c^](#t004fn003){ref-type="table-fn"}   20.5[^b^](#t004fn002){ref-type="table-fn"}   1.6[^c^](#t004fn003){ref-type="table-fn"}    9.5[^c^](#t004fn003){ref-type="table-fn"}    1.1[^b^](#t004fn002){ref-type="table-fn"}    0.5[^c^](#t004fn003){ref-type="table-fn"}   23.2[^c^](#t004fn003){ref-type="table-fn"}
  With persecutory delusions              0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}   50.0[^b^](#t004fn002){ref-type="table-fn"}   16.7[^c^](#t004fn003){ref-type="table-fn"}   16.7[^c^](#t004fn003){ref-type="table-fn"}   16.7[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}    0.0[^c^](#t004fn003){ref-type="table-fn"}   16.7[^c^](#t004fn003){ref-type="table-fn"}
  Without persecutory delusions           3.1[^c^](#t004fn003){ref-type="table-fn"}   2.6[^c^](#t004fn003){ref-type="table-fn"}   12.6[^b^](#t004fn002){ref-type="table-fn"}   21.4[^c^](#t004fn003){ref-type="table-fn"}   1.6[^c^](#t004fn003){ref-type="table-fn"}    8.9[^c^](#t004fn003){ref-type="table-fn"}    1.0[^c^](#t004fn003){ref-type="table-fn"}    0.5[^c^](#t004fn003){ref-type="table-fn"}   22.4[^c^](#t004fn003){ref-type="table-fn"}
  No psychotic symptoms                   3.3[^c^](#t004fn003){ref-type="table-fn"}   2.8[^c^](#t004fn003){ref-type="table-fn"}   12.8[^c^](#t004fn003){ref-type="table-fn"}   19.9[^b^](#t004fn002){ref-type="table-fn"}   1.1[^a^](#t004fn001){ref-type="table-fn"}    8.8[^c^](#t004fn003){ref-type="table-fn"}    0.6[^a^](#t004fn001){ref-type="table-fn"}    0.6[^c^](#t004fn003){ref-type="table-fn"}   22.1[^c^](#t004fn003){ref-type="table-fn"}
  1 psychotic symptom                     0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}   25.0[^c^](#t004fn003){ref-type="table-fn"}   37.5[^b^](#t004fn002){ref-type="table-fn"}   6.2[^a^](#t004fn001){ref-type="table-fn"}    12.5[^c^](#t004fn003){ref-type="table-fn"}   6.2[^a^](#t004fn001){ref-type="table-fn"}    0.0[^c^](#t004fn003){ref-type="table-fn"}   25.0[^c^](#t004fn003){ref-type="table-fn"}
  2 psychotics symptoms                   0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}    0.0[^b^](#t004fn002){ref-type="table-fn"}    50.0[^a^](#t004fn001){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}    0.0[^a^](#t004fn001){ref-type="table-fn"}    0.0[^c^](#t004fn003){ref-type="table-fn"}   0.0[^c^](#t004fn003){ref-type="table-fn"}

^a^: p ≤ 0.01;

^b^: p ≤ 0.05;

^c^: p \> 0.05;

CVA: cerebrovascular accident; CET: Head Trauma; DEP: Reported Depression; DM: Diabetes Mellitus; EPI: Epilepsy; AMI: Acute Myocardial Infarction; SYP: Syphilis; CD: Chagas Disease; ART: Arthritis.

When we compared individuals who reported at least one psychotic symptom with those without psychotic symptoms, there was a higher frequency of epilepsy (6.2% vs. 1.1%, p ≤ 0.01), diabetes (37.5% vs. 19.9%, p ≤ 0.05) and syphilis (6.2% vs. 0.6%, p ≤ 0.01). In those elderly people who reported at least 2 psychotic symptoms epilepsy was again more frequently observed (50.0% vs. 1.1%, p ≤ 0.01) ([Table 4](#pone.0178471.t004){ref-type="table"}).

Logistic regression {#sec016}
-------------------

At phase II, Epilepsy was shown to be a statistically predictive variable for auditory (OR: 15.83) and visual or tactile hallucinations (OR: 7.75), while lower MMSE scores as well as reported depression were predictive of persecutory delusions (OR: 6.48) ([Table 5](#pone.0178471.t005){ref-type="table"}).

10.1371/journal.pone.0178471.t005

###### Different types of psychotic symptoms and respective predictors.

![](pone.0178471.t005){#pone.0178471.t005g}

                                    Beta (SE)        OR      95% IC Exp (B)   p
  --------------------------------- ---------------- ------- ---------------- -------
  *Auditory Hallucinations*                                                   
   Epilepsy                         2.76 (1.26)      15.83   1.34--187.25     0.028
  *Visual/Tactile Hallucinations*                                             
   Epilepsy                         2.05 (1.21)      7.75    0.72--83.00      0.091
  *Persecutory Delusions*                                                     
   MMSE                             \- 0.32 (0.09)   0.72    0.60--0.88       0.00
   Depression                       1.87 (0.97)      6.48    0.97--43.47      0.05

Conversion to cognitive impairment {#sec017}
----------------------------------

In the present study, 57.8% of individuals with psychotic symptoms and without dementia at Phase I developed cognitive impairment during the 7 year follow up period. Comparison of these individuals with those who did not develop cognitive impairment showed that lower MMSE mean score (19.5 vs. 24.0, p ≤ 0.01) and greater functional impairment (B-ADL 3.3 vs. 2.1, p ≤ 0.01) were predictors of conversion. Of the psychotic symptoms studied, the presence of visual/tactile hallucinations was the only statistically predictive variable for subsequent development of cognitive impairment (OR: 5.66) ([Table 6](#pone.0178471.t006){ref-type="table"}).

10.1371/journal.pone.0178471.t006

###### Psychotic symptoms and their associations to cognitive impairment conversion rates, after 7 years follow-up.

![](pone.0178471.t006){#pone.0178471.t006g}

                                  Beta (SE)             OR     95% IC Exp (B)   p
  ------------------------------- --------------------- ------ ---------------- -------
  Auditory Hallucinations         1.77 (1.17)           5.86   0.58--58,74      0.132
  Visual/Tactile Hallucinations   1.73 (0.87)           5.66   1.04--30.86      0.045
  Persecutory Delusion            \- 24.41 (30468.61)   2.48   0.00 --a         0.999

Discussion {#sec018}
==========

Although there are two previous studies \[[@pone.0178471.ref002],[@pone.0178471.ref003]\], to the best of our knowledge this is the first study to have evaluated the incidence of psychotic symptoms in the elderly population of a developing country. The main finding of this study is an incidence of 8% of at least one psychotic symptom in a seven-year follow-up period, which is higher than the 4.8% incidence previously reported in the literature \[[@pone.0178471.ref002],[@pone.0178471.ref003]\].

Although these authors also argued that using information provided by key informants, the incidence could be as high as 8.0% \[[@pone.0178471.ref003]\], the present study specified more clearly the incidence of each type of psychotic symptom and used a broader cognitive impairment screening tool. However, we have found a similar incidence rate of visual or tactile hallucinations (4.5%) and persecutory delusions (3%) as previously reported elsewhere \[[@pone.0178471.ref003]\]. In the first phase of our study, similar to the second phase, visual/tactile hallucinations were found to be the most prevalent (7.8%) followed by auditory hallucinations (7.5%) then persecutory delusions (2.9%) \[[@pone.0178471.ref007]\].

Cognitive performance {#sec019}
---------------------

Individuals with at least one psychotic symptom had an average of 3 points lower MMSE score when compared with those without such symptoms. Indeed Henderson et al., 1998 have already reported an association between lower MMSE scores and the incidence of psychotic symptoms in older subjects without cognitive impairment \[[@pone.0178471.ref002]\]. In the first phase of our study, individuals with persecutory delusions had a lower MMSE score than those without persecutory delusions (more than 3 points), which we again observed in the second phase, but with a larger difference (more than 6 points) \[[@pone.0178471.ref007]\]. This may suggest that it is the presence of persecutory delusions in particular that has the greatest impact on cognition, more so than hallucinations.

Although not statistically significant, a higher B-ADL score was found in subjects with psychotic symptoms. B-ADL scores from the second phase were higher than those from the first study phase, which indicates a possible functional decline during the 7 years between evaluations.

Socioeconomic aspects {#sec020}
---------------------

This study was the first to examine the correlation between psychotic symptoms and socioeconomic variables. We found a trend for an association between the presence of psychotic symptoms and lower socioeconomic status; psychotic symptoms occurred more frequently in classes C and D than in classes A and B. This is a similar finding to the first study phase, where the association between psychotic symptoms and lower socioeconomic class was evident \[[@pone.0178471.ref007]\].

We also observed a greater tendency to use the public health system and health insurance amongst individuals with psychotic symptoms, although not statistically significant. This knowledge could improve the organization of these services and help to provide better diagnostic screening and treatment of such patients.

Comorbidities {#sec021}
-------------

A high level of medical comorbidity was encountered in this sample, with more than 83% of subjects reporting at least one condition. Older populations have a vulnerability for the co-occurrence of physical and mental health problems \[[@pone.0178471.ref002]\], a relationship that has been well described in the literature since the first studies of psychotic symptoms in elderly people \[[@pone.0178471.ref002],[@pone.0178471.ref018]\].

Epilepsy, depression, syphilis and diabetes were the most strongly associated with psychotic symptoms. Epilepsy was significantly more frequently reported by both individuals with at least one and at least two psychotic symptoms, and 2--7% of patients suffering from epilepsy had psychotic symptoms \[[@pone.0178471.ref019]\]. This association has several possible causes: subictal limbic system activity, use of anticonvulsants, changes in dopaminergic receptors, changes in cerebral blood flow induced by repeated epileptic crises and autoimmune reactions \[[@pone.0178471.ref019],[@pone.0178471.ref020],[@pone.0178471.ref021]\]. New-onset epilepsy in older people has a strong association with dementia \[[@pone.0178471.ref020]\], which is frequently associated with psychotic symptoms. Finally, the presence of psychotic symptoms in epileptic individuals may be explained by a possible prodromal dementia state, which has been reported in the literature \[[@pone.0178471.ref020]\].

The finding of an association between reported depression and persecutory delusions could be related to a possible common origin (degenerative brain changes) \[[@pone.0178471.ref002]\] or to psychotic depression.

Individuals with auditory hallucinations more frequently reported a history of syphilis when compared with individuals without psychotic symptoms. It is known that neurosyphilis can be the underlying cause of various psychiatric syndromes, such as dementia, cognitive impairment and psychotic disorders \[[@pone.0178471.ref022]\]. However, the total number of subjects with a history of syphilis was small, and our data were conflicting. Visual/tactile hallucinations were more frequently found in individuals without syphilis, and while a history of syphilis was more frequently encountered in those with at least one psychotic symptom, this did not hold true in those with at least two psychotic symptoms.

Possible risk factors for psychotic symptoms incidence {#sec022}
------------------------------------------------------

Once the first phase of the study was complete \[[@pone.0178471.ref007]\], we investigated possible risk factors for psychotic symptom incidence using logistic regression. We found that epilepsy was the only predictive factor for hallucinations. Epilepsy increased by almost 16 fold the rate of incident cases of auditory hallucinations and by almost 8 fold that of visual/tactile hallucinations. The possible explanations for this are discussed above.

Importantly we demonstrated a relationship between cognitive impairment and psychotic symptoms. We found that a decrease of one point on the MMSE was associated with a 32% increased risk of development persecutory delusions. The incidence of psychotic symptoms is known to be related to lower scores on the MMSE, the presence of physical symptoms as well as living in a sheltered home \[[@pone.0178471.ref002]\]. During our first phase, individuals with psychotic symptoms performed worse on the MMSE than those without such symptoms \[[@pone.0178471.ref007]\]. Lower MMSE scores were associated with auditory hallucinations and persecutory delusions \[[@pone.0178471.ref007]\]; this association with persecutory delusions was strongly reinforced in this second phase.

Reported depression increased the chances of reporting persecutory delusions by 6.5 times. The association between depression and psychotic symptoms is well established in the literature \[[@pone.0178471.ref002],[@pone.0178471.ref003],[@pone.0178471.ref007]\]. As discussed above, this association may be due to psychotic depression or to a possible common origin.

Conversion to cognitive impairment {#sec023}
----------------------------------

This is the first study to examine psychotic symptoms in elderly individuals without dementia, as well as the conversion rate to cognitive impairment, in the context of a developing country. We found that almost 58% of the non-demented individuals with psychotic symptoms developed cognitive impairment within the 7 years follow-up. This is higher than previously reported figures that range between 18.5--44.0% \[[@pone.0178471.ref003],[@pone.0178471.ref004]\].

The presence of psychotic symptoms increases the risk of developing a dementia syndrome by 2.5--3.5 fold \[[@pone.0178471.ref003],[@pone.0178471.ref004],[@pone.0178471.ref005]\]. The cognitive impairment seen in these individuals develops more rapidly than in the general population and occurs especially in non-memory functions \[[@pone.0178471.ref005]\]. The interval mean between the onset of a psychotic symptom and the development of cognitive impairment is 5 years \[[@pone.0178471.ref003]\].

It was found that visual/tactile hallucinations increased the chance of developing cognitive impairment by almost 6 fold. A similar association has been reported where by hallucinations, particularly visual hallucinations, as well as persecutory delusions have been shown to be related to an increase in the incidence of cognitive impairment in elderly individuals, although an exact relative risk had not been established \[[@pone.0178471.ref003],[@pone.0178471.ref004]\].

The association between dementia and psychotic symptoms is well established \[[@pone.0178471.ref023], [@pone.0178471.ref024]\]. The present study clearly shows that in elderly people without dementia, the presence of psychotic symptoms increases the risk of developing cognitive impairment \[[@pone.0178471.ref003], [@pone.0178471.ref004], [@pone.0178471.ref005]\].

Limitations {#sec024}
-----------

Women are over represented in our study sample, as such it is unclear how well this reflects the elderly population of Sao Paulo as a whole.

The results of this study were obtained over a period of 7 years, this resulted in significant loss to follow-up \[[@pone.0178471.ref025]\]. In fact, 28.6% of the subjects from the first phase of the study could not subsequently be found and 18.8% had died.

Responses to interview questions given the patient or their caregiver may be unreliable and give an under- or overestimation of some variables, this is a limitation of our study as it was heavily reliant on this technique. However, researchers evaluating older subjects found there to be a significant correlation between subject and caregiver reporting of health problems \[[@pone.0178471.ref026]\].

Finally, the CAMDEX screening tool for psychotic symptoms does not take into account time frame or frequency.

Conclusion {#sec025}
==========

We found an incidence of psychotic symptoms and a conversion rate to cognitive impairment that was in in the upper range compared to other reports in the literature. Visual or tactile hallucinations had the highest incidence and were predictive of cognitive impairment. Important relationships were found between the incidence of psychotic symptom and MMSE score, epilepsy, depression, diabetes and syphilis.

Future studies are warranted to better our understanding, and to help prevent the development of psychosis and cognitive impairment in the elderly population.

Supporting information {#sec026}
======================

###### Data bank.

(SAV)

###### 

Click here for additional data file.
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